cti Logo Making Cancer More Treatable
Media / Press Kit /
 
Media Photo
XYOTAX
Pixantrone
 

Online Press Kits for CTI Products

OPAXIO™ (paclitaxel poliglumex, CT-2103; formerly branded as XYOTAX)
Pixantrone



Contact CTI
For media inquiries:
Dan Eramian, T (206) 272-4343
(800) 215-CELL (US)
F (206) 272-4010

Media@ctiseattle.com

back to topback to top



Posted May 13, 2008

Copyright © 2004-2008 Cell Therapeutics, Inc., Seattle, WA, USA. All rights reserved. "Making cancer more treatable" is a registered mark of CTI.